PROM1 and neoplasm: We found in three different mouse models of sarcoma that this multimodal therapy is highly effective in blocking tumor growth, with more than additive increases in DNA damage, total apoptosis, and endothelial cell specific apoptosis, and more than additive decreases in microvessel density, HIF-1α activity, and CD133(+) CSCs.